First Time Loading...

Yield10 Bioscience Inc
NASDAQ:YTEN

Watchlist Manager
Yield10 Bioscience Inc Logo
Yield10 Bioscience Inc
NASDAQ:YTEN
Watchlist
Price: 0.261 USD 0.38% Market Closed
Updated: Apr 23, 2024

Yield10 Bioscience Inc
Cash from Operating Activities

Last Value
3-Years CAGR
5-Years CAGR
Quarterly
Annual
TTM
|

Yield10 Bioscience Inc
Cash from Operating Activities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Yield10 Bioscience Inc
NASDAQ:YTEN
Cash from Operating Activities
$-10.1m
CAGR 3-Years
-5%
CAGR 5-Years
-3%
CAGR 10-Years
9%
Abbvie Inc
NYSE:ABBV
Cash from Operating Activities
$22.8B
CAGR 3-Years
9%
CAGR 5-Years
11%
CAGR 10-Years
14%
Gilead Sciences Inc
NASDAQ:GILD
Cash from Operating Activities
$8B
CAGR 3-Years
-1%
CAGR 5-Years
-1%
CAGR 10-Years
10%
Amgen Inc
NASDAQ:AMGN
Cash from Operating Activities
$8.5B
CAGR 3-Years
-7%
CAGR 5-Years
-6%
CAGR 10-Years
3%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Cash from Operating Activities
$3.5B
CAGR 3-Years
3%
CAGR 5-Years
23%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Cash from Operating Activities
$4.6B
CAGR 3-Years
21%
CAGR 5-Years
16%
CAGR 10-Years
23%

See Also

What is Yield10 Bioscience Inc's Cash from Operating Activities?
Cash from Operating Activities
-10.1m USD

Based on the financial report for Dec 31, 2023, Yield10 Bioscience Inc's Cash from Operating Activities amounts to -10.1m USD.

What is Yield10 Bioscience Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
9%

Over the last year, the Cash from Operating Activities growth was 12%. The average annual Cash from Operating Activities growth rates for Yield10 Bioscience Inc have been -5% over the past three years , -3% over the past five years , and 9% over the past ten years .